Table 1 Distribution of 150 NSCLC patients according to E-cadherin, N-cadherin status, and tumour vascularity

From: Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

  

E-cadherin

N-cadherin

Tumour vascularity

Variables

n

Positive

Negative

P -value

Positive

Negative

P -value

Hypervascular

Hypovascular

P -value

Tumour status

          

 T1

62

36

26

0.1629

20

42

0.9245

39

23

0.0540

 T2

50

27

23

 

16

34

 

20

30

 

 T3

7

1

6

 

2

5

 

3

4

 

 T4

31

15

16

 

8

23

 

20

11

 

Nodal status

          

 N0

106

63

43

0.0100

35

71

0.3265

58

48

0.9847

 N1, N2, N3

44

16

28

 

11

33

 

24

20

 

Pathological stage

          

 Stage I

86

53

33

0.0378

28

58

0.3198

45

41

0.6656

 Stage II

15

4

11

 

3

12

 

8

7

 

 Stage IIIA

18

7

11

 

8

10

 

9

9

 

 Stage IIIB

31

15

16

 

7

24

 

20

11

 

Differentiation

          

 Well

54

32

22

0.2815

17

37

0.9859

37

17

0.0375

 Moderately

50

27

23

 

15

35

 

23

27

 

 Poorly

46

20

26

 

14

32

 

22

24

 

Histology

          

 Adenocarcinoma

86

50

36

0.1088

31

55

0.1344

58

28

0.0070

 Squamous cell carcinoma

50

25

25

 

10

40

 

17

33

 

 Large cell carcinoma

14

4

10

 

5

9

 

7

7

 

Total number of patients

150

79

71

 

46

104

 

82

68

 
Back to article page